Browsing Tag
KRAS
2 posts
Next-gen RNA therapy SIL204 passes key safety milestone as Silexion Therapeutics prepares Phase 2/3 pancreatic cancer study
Find out how Silexion Therapeutics is advancing SIL204 after a key safety milestone in pancreatic cancer research.
Biomea Fusion to take BMF-219 into clinical trials for KRAS solid tumors
Biomea Fusion is all set to take BMF-219 into clinical trials in patients having unresectable, locally advanced, or…